Literature DB >> 9447600

The written-description requirement in UC v. Lilly.

H W Levine1.   

Abstract

Mesh:

Substances:

Year:  1998        PMID: 9447600     DOI: 10.1038/nbt0198-87

Source DB:  PubMed          Journal:  Nat Biotechnol        ISSN: 1087-0156            Impact factor:   54.908


× No keyword cloud information.
  1 in total

1.  CRISPR-Cas9 claim sets and the potential to stifle innovation.

Authors:  Benjamin N Gray; W Murray Spruill
Journal:  Nat Biotechnol       Date:  2017-07-12       Impact factor: 54.908

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.